TET2 and neoplasm: Consistent with the clinical association between CHIP and a myeloid-rich lung tumor microenvironment (Fig 1D), the percentage of Tet2-mutant cells in blood positively correlated with the overall myeloid infiltration in the tumor (Fig 4B).